Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis.

Cancers (Basel) · 2022 · PMC9221317 · PMID 35740494

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

did not reach statistical significanceno p-value reported

In GEP-NEN, there was a clear trend towards shorter survival in the EZH2 high group that did not reach statistical significance, possibly because the EZH2 low group was very small (n = 4).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.